Glycosuria in primary glomerulopathies: prevalence and prognostic significance

Abstract Introduction: Tubular damage is common in glomerular diseases (GD). Glycosuria is a marker of tubular dysfunction and may be used to detect tubular lesion and CKD progression. The aim of this study was to evaluate the prevalence and prognostic value of glycosuria at the time of diagnosis in primary glomerulopathies (PG). Methods: We conducted a 24-month retrospective study in patients diagnosed with PG in our center between 2009 and 2020. We excluded diabetic patients, use of SGLT2 inhibitors, transplant patients, and secondary GD. Patients were divided in two groups according to their glycosuria status at diagnosis. Results: We studied 115 patients. Global prevalence of glycosuria was 10% (n=11) and membranous nephropathy (MN) had the highest prevalence (n=5, 17.9%). We found that patients with glycosuria had higher serum creatinine (2.4 vs. 1.2 mg/dL, p=0.030), higher albuminuria (4.8 vs. 1.9 g/g, p=0.004), and lower serum albumin (2.3 vs. 3.2 g/dL, p=0.021). We did not find association with histological prognostic factors. At the end of follow-up, patients with glycosuria had higher prevalence of the composite outcome of stage 5D CKD or 50% increase in basal SCr (45.5% vs. 17.3%, p=0.037). In patients with MN, results were similar but we were able to find an association of glycosuria with more severe interstitial fibrosis and tubular atrophy (25.0 vs. 0.0 %, p=0.032). Conclusion: Ten percent of our patients with PG have glycosuria. Glycosuria at the time of diagnosis was associated with more severe clinical presentation and worst renal outcome. The association with higher albuminuria suggests that tubular function has an impact on the severity and outcomes of PG.

Saved in:
Bibliographic Details
Main Authors: Ormonde,Carolina, Laranjinha,Ivo, Gil,Célia, Gonçalves,Margarida, a Gaspar,August
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Nefrologia 2022
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022000100026
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0101-28002022000100026
record_format ojs
spelling oai:scielo:S0101-280020220001000262022-03-17Glycosuria in primary glomerulopathies: prevalence and prognostic significanceOrmonde,CarolinaLaranjinha,IvoGil,CéliaGonçalves,Margaridaa Gaspar,August Glycosuria Glomerulonephritis Prognosis Albuminuria Kidney Tubules, Proximal Renal Insufficiency, Chronic Abstract Introduction: Tubular damage is common in glomerular diseases (GD). Glycosuria is a marker of tubular dysfunction and may be used to detect tubular lesion and CKD progression. The aim of this study was to evaluate the prevalence and prognostic value of glycosuria at the time of diagnosis in primary glomerulopathies (PG). Methods: We conducted a 24-month retrospective study in patients diagnosed with PG in our center between 2009 and 2020. We excluded diabetic patients, use of SGLT2 inhibitors, transplant patients, and secondary GD. Patients were divided in two groups according to their glycosuria status at diagnosis. Results: We studied 115 patients. Global prevalence of glycosuria was 10% (n=11) and membranous nephropathy (MN) had the highest prevalence (n=5, 17.9%). We found that patients with glycosuria had higher serum creatinine (2.4 vs. 1.2 mg/dL, p=0.030), higher albuminuria (4.8 vs. 1.9 g/g, p=0.004), and lower serum albumin (2.3 vs. 3.2 g/dL, p=0.021). We did not find association with histological prognostic factors. At the end of follow-up, patients with glycosuria had higher prevalence of the composite outcome of stage 5D CKD or 50% increase in basal SCr (45.5% vs. 17.3%, p=0.037). In patients with MN, results were similar but we were able to find an association of glycosuria with more severe interstitial fibrosis and tubular atrophy (25.0 vs. 0.0 %, p=0.032). Conclusion: Ten percent of our patients with PG have glycosuria. Glycosuria at the time of diagnosis was associated with more severe clinical presentation and worst renal outcome. The association with higher albuminuria suggests that tubular function has an impact on the severity and outcomes of PG.info:eu-repo/semantics/openAccessSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology v.44 n.1 20222022-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022000100026en10.1590/2175-8239-jbn-2021-0115
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ormonde,Carolina
Laranjinha,Ivo
Gil,Célia
Gonçalves,Margarida
a Gaspar,August
spellingShingle Ormonde,Carolina
Laranjinha,Ivo
Gil,Célia
Gonçalves,Margarida
a Gaspar,August
Glycosuria in primary glomerulopathies: prevalence and prognostic significance
author_facet Ormonde,Carolina
Laranjinha,Ivo
Gil,Célia
Gonçalves,Margarida
a Gaspar,August
author_sort Ormonde,Carolina
title Glycosuria in primary glomerulopathies: prevalence and prognostic significance
title_short Glycosuria in primary glomerulopathies: prevalence and prognostic significance
title_full Glycosuria in primary glomerulopathies: prevalence and prognostic significance
title_fullStr Glycosuria in primary glomerulopathies: prevalence and prognostic significance
title_full_unstemmed Glycosuria in primary glomerulopathies: prevalence and prognostic significance
title_sort glycosuria in primary glomerulopathies: prevalence and prognostic significance
description Abstract Introduction: Tubular damage is common in glomerular diseases (GD). Glycosuria is a marker of tubular dysfunction and may be used to detect tubular lesion and CKD progression. The aim of this study was to evaluate the prevalence and prognostic value of glycosuria at the time of diagnosis in primary glomerulopathies (PG). Methods: We conducted a 24-month retrospective study in patients diagnosed with PG in our center between 2009 and 2020. We excluded diabetic patients, use of SGLT2 inhibitors, transplant patients, and secondary GD. Patients were divided in two groups according to their glycosuria status at diagnosis. Results: We studied 115 patients. Global prevalence of glycosuria was 10% (n=11) and membranous nephropathy (MN) had the highest prevalence (n=5, 17.9%). We found that patients with glycosuria had higher serum creatinine (2.4 vs. 1.2 mg/dL, p=0.030), higher albuminuria (4.8 vs. 1.9 g/g, p=0.004), and lower serum albumin (2.3 vs. 3.2 g/dL, p=0.021). We did not find association with histological prognostic factors. At the end of follow-up, patients with glycosuria had higher prevalence of the composite outcome of stage 5D CKD or 50% increase in basal SCr (45.5% vs. 17.3%, p=0.037). In patients with MN, results were similar but we were able to find an association of glycosuria with more severe interstitial fibrosis and tubular atrophy (25.0 vs. 0.0 %, p=0.032). Conclusion: Ten percent of our patients with PG have glycosuria. Glycosuria at the time of diagnosis was associated with more severe clinical presentation and worst renal outcome. The association with higher albuminuria suggests that tubular function has an impact on the severity and outcomes of PG.
publisher Sociedade Brasileira de Nefrologia
publishDate 2022
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002022000100026
work_keys_str_mv AT ormondecarolina glycosuriainprimaryglomerulopathiesprevalenceandprognosticsignificance
AT laranjinhaivo glycosuriainprimaryglomerulopathiesprevalenceandprognosticsignificance
AT gilcelia glycosuriainprimaryglomerulopathiesprevalenceandprognosticsignificance
AT goncalvesmargarida glycosuriainprimaryglomerulopathiesprevalenceandprognosticsignificance
AT agasparaugust glycosuriainprimaryglomerulopathiesprevalenceandprognosticsignificance
_version_ 1756392746733535232